The FDA changes booster guidance
The FDA made three major decisions this week about Pfizer’s COVID-19 booster vaccination.
Extended Emergency Use authorization
The FDA extended Emergency use authorization for Pfizer’s vaccine approving a vaccine booster for 12–15 year old’s.
timeline to receive a booster
The FDA is shortening the time of completion of the first two doses and the booster to five months instead of the original six months for everyone over the age of 12.
Allowing some children under 12 to receive a booster
The FDA announced they are now allowing a third vaccination for kids 5–11 that are immunocompromised. Kids that fall into this group are children that have had a solid organ transplant or diagnosed with conditions that are equivalent.
As always the CDC needed to sign off on the decisions made by the FDA and they did so Wednesday.
The FDA says if you have any questions about the vaccine and whether your child should get the booster you should always consult your child’s pediatrician.